| Trial ID: | L3809 |
| Source ID: | NCT00655044
|
| Associated Drug: |
Insulin Detemir
|
| Title: |
Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes
|
| Acronym: |
PREDICTIVE™
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 1|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: insulin detemir
|
| Outcome Measures: |
Primary: HbA1C, after 12 weeks | Secondary: Safety, during treatment
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
3637
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2007-05
|
| Completion Date: |
2008-01
|
| Results First Posted: |
|
| Last Update Posted: |
2016-10-28
|
| Locations: |
Novo Nordisk Investigational Site, Moscow, 119330, Russian Federation
|
| URL: |
https://clinicaltrials.gov/show/NCT00655044
|
